| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 13/10/2017 | 23:05 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:KITE | Kite Pharma, Inc. |
| 05/10/2017 | 21:44 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:KITE | Kite Pharma, Inc. |
| 03/10/2017 | 23:12 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:KITE | Kite Pharma, Inc. |
| 03/10/2017 | 22:56 | Edgar (US Regulatory) | Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr) | NASDAQ:KITE | Kite Pharma, Inc. |
| 03/10/2017 | 22:44 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:KITE | Kite Pharma, Inc. |
| 03/10/2017 | 15:03 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:KITE | Kite Pharma, Inc. |
| 03/10/2017 | 14:46 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:KITE | Kite Pharma, Inc. |
| 03/10/2017 | 14:45 | Business Wire | Gilead Sciences Completes Acquisition of Kite Pharma, Inc. | NASDAQ:KITE | Kite Pharma, Inc. |
| 03/10/2017 | 14:17 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:KITE | Kite Pharma, Inc. |
| 03/10/2017 | 14:00 | Business Wire | Gilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc. | NASDAQ:KITE | Kite Pharma, Inc. |
| 26/09/2017 | 14:30 | Business Wire | Gilead Sciences and Kite Pharma Announce Expiration of Hart-Scott-Rodino Waiting Period | NASDAQ:KITE | Kite Pharma, Inc. |
| 05/09/2017 | 22:13 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:KITE | Kite Pharma, Inc. |
| 05/09/2017 | 18:24 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:KITE | Kite Pharma, Inc. |
| 01/09/2017 | 23:28 | Edgar (US Regulatory) | Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) | NASDAQ:KITE | Kite Pharma, Inc. |
| 01/09/2017 | 23:22 | Edgar (US Regulatory) | Written Communication Relating to an Issuer or Third Party (sc To-c) | NASDAQ:KITE | Kite Pharma, Inc. |
| 01/09/2017 | 00:23 | PR Newswire (US) | SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Kite Pharma, Inc. - KITE | NASDAQ:KITE | Kite Pharma, Inc. |
| 30/08/2017 | 18:50 | Dow Jones News | FDA Approves First Gene Therapy in U.S. -- Update | NASDAQ:KITE | Kite Pharma, Inc. |
| 30/08/2017 | 18:25 | Dow Jones News | FDA Approves First Gene Therapy in U.S. | NASDAQ:KITE | Kite Pharma, Inc. |
| 30/08/2017 | 00:46 | PR Newswire (US) | Harwood Feffer LLP Announces Investigation of Kite Pharma, Inc. | NASDAQ:KITE | Kite Pharma, Inc. |
| 29/08/2017 | 09:02 | Dow Jones News | Gilead Bets $11 Billion On New Cancer Therapy -- WSJ | NASDAQ:KITE | Kite Pharma, Inc. |
| 29/08/2017 | 09:02 | Dow Jones News | What's News: Business & Finance -- WSJ | NASDAQ:KITE | Kite Pharma, Inc. |
| 29/08/2017 | 01:56 | Dow Jones News | Gilead to Buy Kite Pharma for Roughly $11 Billion -- 2nd Update | NASDAQ:KITE | Kite Pharma, Inc. |
| 28/08/2017 | 18:26 | Dow Jones News | The Promising New Cancer Treatment Behind Gilead's $11 Billion Deal | NASDAQ:KITE | Kite Pharma, Inc. |
| 28/08/2017 | 17:55 | Business Wire | ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kite Pharma, Inc. | NASDAQ:KITE | Kite Pharma, Inc. |
| 28/08/2017 | 15:29 | Dow Jones News | Hot Stocks to Watch in the U.S. and Canada | NASDAQ:KITE | Kite Pharma, Inc. |
| 28/08/2017 | 14:46 | Dow Jones News | Gilead to Buy Kite Pharma for Roughly $11 Billion -- Update | NASDAQ:KITE | Kite Pharma, Inc. |
| 28/08/2017 | 13:00 | Business Wire | Gilead Sciences to Acquire Kite Pharma for $11.9 Billion | NASDAQ:KITE | Kite Pharma, Inc. |
| 28/08/2017 | 12:59 | Dow Jones News | Gilead to Buy Kite Pharma for Roughly $11 Billion in Cash | NASDAQ:KITE | Kite Pharma, Inc. |
| 17/08/2017 | 14:30 | Business Wire | Kite Highlights Publication from the National Cancer Institute Demonstrating Responses in Patients with Metastatic Solid Tumo... | NASDAQ:KITE | Kite Pharma, Inc. |
| 14/08/2017 | 23:10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KITE | Kite Pharma, Inc. |